Accenture Brings Open Partner Ecosystem for Drug Discovery

Shutterstock photo

Accenture plc ACN has modeled an open partner ecosystem, aimed at helping independent software vendors (ISVs) and life sciences companies collaborate to speed up and enhance drug discovery.

The ecosystem is an integral part of the cloud-based informatics research platform, which is being developed by Accenture in collaboration with Merck MRK on Amazon’s AMZN Amazon Web Services (“AWS”). The platform enables scientific research-based organizations in the life sciences industry to quickly access, aggregate and analyze research data from multiple applications. It facilitates easier collaboration across the R&D enterprise, including external partners.

The new ecosystem will enable ISVs leverage the platform’s use of open, industry-standard-based application programming interfaces (APIs) to integrate technology components, applications and content into the platform.

As a result, life sciences companies will be able to provide researchers access to innovative capabilities such as small-molecule and biological-entity registration, biological assay data capture, genomics data analysis, image storage and analysis and artificial intelligence.

In the past year, shares of Accenture have gained 7% compared with the 1.7% rise of the Zacks S&P 500 composite.

To Conclude

We believe that the latest move will help Accenture boost its Products segment as it comprises the Life Sciences industry group, which serves pharmaceutical, medical technology and biotechnology companies. Performance of this segment was particularly strong in the last reported quarter, with revenues increasing 12% on a year-over-year basis.

Zacks Rank & Stocks to Consider

Accenture currently carries a Zacks Rank #3 (Hold). You can see  the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

A better-ranked stock in the broader Zacks Business Services sector is WEX Inc. WEX , carrying a Zacks Rank #2 (Buy). The long-term expected EPS (three to five years) growth rates for WEX is 15%.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks’ 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report, Inc. (AMZN): Free Stock Analysis Report

Merck & Co., Inc. (MRK): Free Stock Analysis Report

WEX Inc. (WEX): Free Stock Analysis Report

Accenture PLC (ACN): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.

Wealth Empire Newsletter
Register now for free updates and alerts

Subscribe By

Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.